# LBBW VC

> LBBW VC is a VC fund in Stuttgart backing Software and Biotechnology. See 50 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Stuttgart, Germany
- Total investments: 50
- Last investment: Feb 2026
- Lead investor: 30%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/lbbw-venture-capital-gmbh/about/
- X (Twitter): https://www.twitter.com/lbbwventure
- Website: http://www.lbbwvc.de

LBBW VC is a VC fund in Stuttgart focused on Software and Biotechnology. LBBW Venture invests in brilliant entrepreneurs raising a late seed, Series A or Series B round within the DACH region.

## Contacts

5 contacts available for LBBW VC. Shizune tracks 5 team members at LBBW VC. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/lbbw-venture-capital-gmbh?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $850k–$13M |
| Series A | $2.7M–$17M |
| Series B | $1.7M–$62M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 9 | 18% |
| Biotechnology | 9 | 18% |
| Health Care | 8 | 16% |
| Medical | 4 | 8% |
| Enterprise Software | 4 | 8% |

78 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 12 | 24% |
| Seed | 9 | 18% |
| Series B | 7 | 14% |
| Funding Round | 5 | 10% |
| Series C | 3 | 6% |

12 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 33 | 66% |
| United Kingdom | 2 | 4% |
| Switzerland | 1 | 2% |
| United States | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Andreas von Richter | Managing Partner | 8 | https://shizune.co/investors/profile/andreas-von-richter |
| Harald Poth | Senior Investment Manager (Life Sciences) | 0 | https://shizune.co/investors/profile/harald-poth |
| Markus Kazmaier | Analyst | 0 | https://shizune.co/investors/profile/markus-kazmaier |
| Maximilian Naumow | Investment Manager | 0 | https://shizune.co/investors/profile/maximilian-naumow-3753 |
| Patrick Herlinger | Investment Manager | 4 | https://shizune.co/investors/profile/patrick-herlinger |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Oska Health | Oska Health delivers digital-enabled care solutions for chronic kidney disease patients, a top clinical need for healthcare payers. By leveraging evidence-based medical best practices and behavioral science, Oska Health aims to empower individuals with kidney disease to mitigate their risk of cardiovascular complications and kidney failure whilesimultaneously lowering costs of care. The company partners with healthcare payers to provide a comprehensive solution that includes a personal coach, a state-of-the-art health app, and intelligent treatment plan algorithms, all designed to help individuals establish new routines and achieve optimal health outcomes. | $13M | Seed | Feb 26, 2026 |  |
| Blockbrain | Blockbrain is a technology company that provides a generative AI platform and tools designed to help developers and enterprises build, deploy, and manage AI-powered applications and workflows. The company’s platform includes modular components for natural language processing, vector search, prompt management, and customizable AI model orchestrationthat support integration into software products and internal systems. Its offerings enable technical teams to create contextual knowledge layers, automated reasoning chains, and AI-assisted interfaces that leverage both proprietary and third-party models.Blockbrain also supplies SDKs, APIs, and development frameworks that help streamline application development, model tuning, and content generation across use cases such as intelligent search, summarization, and automated responses. The company works with partners and customers to tailor solutions that align with existing tech stacks and operational goals, supporting collaboration across engineering and product teams. Its platform emphasizes flexibility in model choice, data connectivity, and deployment options to accommodate diverse AI application requirements. | $20.8M | Series A | Feb 12, 2026 |  |
| Metergrid | Metergrid is an energy technology company that provides software and services to plan and execute tenant electricity projects using locally generated solar power for multi-party properties. It offers tools that support economic analysis, technical setup, billing, and digital management of decentralized energy systems for property owners and energyservice providers. The company’s platform integrates project planning, metering technology, and administrative software to help stakeholders manage energy flows and customer contracts. Metergrid also works with partner networks to coordinate installation and operational support for photovoltaic systems. Its offerings aim to simplify the deployment and ongoing administration of tenant electricity models for real estate stakeholders. | $12M | Series A | Jan 29, 2026 |  |
| Exciva | exciva is a Provider of targeted drug rescue program intended to involve pharmaceutical research and development based in Heidelberg, Germany. The company's program has been formulated for developing symptomatic and disease-modifying treatments, therapies, cures, prophylactics, supplements, formulations and methods of making and using suchcompositions, enabling the healthcare industry to access their program for rescuing and reusing approved drugs for new indications and new uses. | $62.2M | Series B | Jan 20, 2026 |  |
| Workdry International | Workdry International provides designed water and wastewater management and treatment solutions. | $660M | Debt Financing | Aug 21, 2025 |  |
| Venture Global | Venture Global LNG is a low-cost producer of liquefied natural gas pipelines. Working with a global LNG technology vendor, Venture Global intends to configure a 10.0 MTPA LNG facility utilizing efficient, low-cost, mid-scale LNG liquefaction technology. It was founded in 2013 and is headquartered in Washington, District of Columbia. | $15.1B | Post-IPO Debt | Jul 28, 2025 |  |
| specter automation | Construction is the second least digitized sector in the world with 96% of all data being unused. Although detailed planning data is created upfront, a lack of suitable digital tools prevents its transfer to the construction site. SPECTER’s web-based construction management software uniquely incorporates the core components of constructionplanning, reducing the organizational burden on construction management and helping to meet project timelines and budgets. | $5.4M | Seed | Mar 26, 2025 |  |
| Metergrid | Metergrid is an energy technology company that provides software and services to plan and execute tenant electricity projects using locally generated solar power for multi-party properties. It offers tools that support economic analysis, technical setup, billing, and digital management of decentralized energy systems for property owners and energyservice providers. The company’s platform integrates project planning, metering technology, and administrative software to help stakeholders manage energy flows and customer contracts. Metergrid also works with partner networks to coordinate installation and operational support for photovoltaic systems. Its offerings aim to simplify the deployment and ongoing administration of tenant electricity models for real estate stakeholders. |  | Seed | Feb 19, 2025 |  |
| Meshcapade | Meshcapade (Germany) is revolutionizing the world of human body modeling, sizing, and animation. Meshcapade employs a state of the art statistical model of body shape that encodes realistic shapes, sizes, and motions. We make animating, simulating, and recognizing human bodies effortless, and to bring realistic virtual humans into simulation and3D environments. | $6M | Convertible Note | Feb 05, 2025 |  |
| leon nanodrugs | leon nanodrugs a specialised product development company dedicated to developing a pipeline of enhanced versions of existing drug products, and providing services to enable pre-clinical and clinical stage formulations for their clients NCEs or branded established drugs.leon-nanodrugs offers access to the next generation of nano-formulated drugswith meaningful differentiation and added patient benefits.They specialize in improving the bioavailability of poorly water soluble drugs by using leon’s proprietary MJR® Technology platform to create either polymeric or crystalline nanoparticles. |  | Series D | Aug 06, 2024 |  |

10 of 50 investments shown.

## Co-investors
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund, 13 deals together
- [KfW](https://shizune.co/investors/profile/kfw) — VC Fund, 10 deals together
- [Andera Partners](https://shizune.co/investors/profile/edmond-de-rothschild-investment-partners) — VC Fund, 6 deals together
- [Capnamic](https://shizune.co/investors/profile/capnamic-ventures) — VC Fund, 4 deals together
- [BayBG Venture Capital](https://shizune.co/investors/profile/baybg) — VC Fund, 3 deals together
- [Bayern Kapital](https://shizune.co/investors/profile/bayern-kapital) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [Hardware Investors in Germany](https://shizune.co/investors/hardware-investors-germany)
- [Health Care VC Funds in Germany](https://shizune.co/investors/health-care-vc-funds-germany)
- [Health Care Investors in Germany](https://shizune.co/investors/health-care-investors-germany)
- [Hardware VC Funds in Germany](https://shizune.co/investors/hardware-vc-funds-germany)
- [Enterprise Software Investors in Germany](https://shizune.co/investors/enterprise-software-investors-germany)
- [Biotech VC Funds in Germany](https://shizune.co/investors/biotech-vc-funds-germany)

## FAQ

### What does LBBW VC invest in?

LBBW VC invests primarily in Software, Biotechnology and Health Care startups, most often at Series A and Seed stage. Most of the 50 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is LBBW VC's check size?

LBBW VC typically joins rounds of $850k–$13M at Seed, $2.7M–$17M at Series A and $1.7M–$62M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds LBBW VC participates in.

### How do I contact LBBW VC?

Public channels for LBBW VC include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at LBBW VC?

The team at LBBW VC includes Andreas von Richter (Managing Partner), Harald Poth (Senior Investment Manager (Life Sciences)) and Markus Kazmaier (Analyst). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co